A r t i c l e s and chromosome 22q12 (including HORMAD2 and several other genes) 3, 4 . Cumulatively, these GWAS loci explain about 5% of total disease risk. Additionally, variation in risk allele frequency explains a substantial fraction of the observed variation by ancestry group in disease prevalence, with risk alleles having substantially higher frequencies in Asians in comparison to individuals of European ancestry 3 . These findings raise the possibility that additional disease-associated loci might have been missed owing to fixation of risk alleles in Asian populations. To identify new disease-associated loci, we performed a GWAS twice the size of the previous largest study and have analyzed a discovery cohort based predominantly on subjects of European ancestry.
RESULTS

Study design
In stage 1 (discovery), we performed a genome-wide analysis in 2,747 biopsy-confirmed cases and 3,952 controls, including 3 new cohorts comprising 1,553 cases and 3,050 controls of European ancestry and the previously published Han Chinese discovery cohort of 1, 194 cases and 902 controls ( Table 1 , Supplementary Tables 1-3 and Supplementary Note). For each cohort, we performed principalcomponent analyses to assure adequate ancestry matching between cases and controls ( Supplementary Fig. 1 ). All individual samples were imputed to a common set of >1 million SNPs ( Supplementary Table 4 ) using ancestry-matched HapMap 3 reference panels ( Supplementary  Fig. 2) . Primary association testing was performed after accounting for imputation uncertainty and significant principal components of ancestry ( Supplementary Table 3 ). We detected a minimal effect of population stratification within each cohort (genomic inflation factor (λ) = 1.01-1.06; Supplementary Fig. 3) . The association results from individual cohorts were combined using genome-wide fixed-effects meta-analysis. We identified multiple suggestive signals and several distinct peaks exceeding genome-wide significance in the joint analysis of the discovery cohorts ( Supplementary Fig. 4 ). Top signals, defined by association P < 5 × 10 −5 , were genotyped in an additional 4,911 cases and 9,002 controls (stage 2), and a meta-analysis was performed to identify genome-wide significant signals across the combined cohorts of 20,612 individuals. This two-stage design was adequately powered to detect odds ratios (ORs) as small as 1.15-1. 25 ( Supplementary Table 1 ).
In the combined analysis, we identified six new genome-wide significant signals ( Fig. 1, Table 2, Supplementary Fig. 5 and Supplementary Tables 5-7) . These included four signals in three new loci at 1p13 (VAV3 locus), 9q34 (CARD9 locus) and 16p11 (ITGAM-ITGAX locus) and two new independent signals within the previously known HLA-DQ-HLA-DR and DEFA regions. We also confirmed associations at all nine previously identified loci at 6p21 (HLA-DQ-HLA-DR, TAP1-PSMB8 and HLA-DP loci), 1q32 (CFHR3-CFHR1 deletion locus), 8p23 (DEFA locus), 17p13 (TNFSF13 locus) and 22q12 (HORMAD2 locus).
New IgAN susceptibility loci
The ITGAM-ITGAX locus at 16p11 represented the strongest new non-HLA signal (Fig. 1b) . The top signal, rs11574637, was an intronic SNP in ITGAX, which encodes leukocyte-specific integrin αX, a component of complement receptor 4 (CR4) involved in leukocyte cell adhesion and migration and the phagocytosis of complement-coated particles by monocytes and macrophages 6 . This SNP was genome-wide significant in the discovery phase (OR = 1.47, P = 2.8 × 10 −10 ) and in the combined metaanalysis (OR = 1.32, P = 8.1 × 10 −13 ). It is noteworthy that the risk allele (T) at this locus represents an ancestral (chimpanzee) allele with a frequency of 0.82 in Europeans and a frequency of 1.0 in Asians, explaining why this strong signal was not detected in previous GWAS based on Asian discovery cohorts. Previous studies have shown that rs11574637 is associated with risk of systemic lupus erythematosus (SLE) 7 . Interestingly, the IgAN risk allele (T) is protective against SLE, suggesting a complex interplay between these two disorders causing nephritis.
In addition, we detected another genome-wide significant intergenic SNP in this region, rs11150612 (P = 1.3 × 10 −11 ), which was poorly correlated with rs11574637 (r 2 = 0 for Asians and r 2 = 0.12 for Europeans). Stratified conditional analysis strongly suggested that rs11150612 represented an independent signal, although this finding will require confirmation in larger Europeanancestry cohorts (conditioned OR = 1.13, P = 1.6 × 10 −6 ; Supplementary Table 8 ). The risk allele at rs11150612 is a derived (non-chimpanzee) allele with a frequency of 0.36 in Europeans and a frequency of 0.75 in Asians. This allele is also associated with increased expression of ITGAX in peripheral blood cells 8 ( Supplementary Table 9 ). Moreover, examination of 1000 Genomes Project data showed that this risk allele was in strong linkage disequilibrium (LD) with an ITGAX missense variant predicted to be damaging (rs2230429, p.Pro517Arg, r 2 = 0.97; not typed in our study; Supplementary Table 10) .
We observed a genome-wide significant signal at 9q34 corresponding to rs4077515 (OR = 1.16, P = 1.2 × 10 −9 ; Fig. 1c ), which was supported by data from both the Asian and European cohorts (Supplementary Table 6 ). The rs4077515[T] risk allele results in a p.Ser12Asn substitution in CARD9 (caspase recruitment domaincontaining protein 9, an adaptor protein that promotes the activation of nuclear factor (NF)-κB in macrophages). This substitution is associated with higher expression of CARD9 in monocytes 9 , lymphoblastoid cell lines 10 and peripheral blood cells 8 npg Table 9 ). The same allele also confers increased risk of ulcerative colitis and Crohn's disease 11, 12 ( Supplementary Table 11 ).
(Supplementary
The top signal at 1p13, rs17019602 ( Fig. 1d) , was an intronic SNP in VAV3, a gene encoding a guanine nucleotide exchange factor for Rho GTPases that is important for B-and T-lymphocyte development and antigen presentation 13, 14 (OR = 1.17, P = 6.8 × 10 −9 ). Data for both the Asian and European cohorts supported this association ( Supplementary Table 6 ). A common variant in VAV3 has previously Observed -log (P) Figure 1 Results of the combined meta-analysis across all 20,612 individuals. (a-g) Manhattan plot (a) and regional plots for genome-wide significant loci outside of the HLA region, including the ITGAM-ITGAX locus (b), the CARD9 locus (c), the VAV3 locus (d), the DEFA locus (the shaded area represents the region of common duplications involving the DEFA1 and DEFA3 genes) (e), the CFHR3-CFHR1 deletion locus (the shaded area represents the deletion of the CFHR3 and CFHR1 genes) (f) and the HORMAD2 locus (g). The x axis presents physical distance in kilobases (hg18 coordinates), and the y axis presents −log P values for association statistics. The dotted horizontal line in a represents a genome-wide significance level (P = 5 × 10 −8 ). CNP, copy number polymorphism.
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A r t i c l e s been associated with hypothyroidism, likely secondary to autoimmune etiology 15 . However, the hypothyroidism risk allele showed no LD with rs17019602 (r 2 = 0), indicating that the IgAN signal represents a distinct allele at this locus.
Identification of new and ancestry-specific signals at known loci
The strongest signal in the present GWAS represents a new association in the HLA-DQ-HLA-DR locus (rs7763262: OR = 1.41, P = 1.8 × 10 −38 ; Supplementary Fig. 6 ). This signal persisted after conditioning on the previously described SNPs in the region (conditioned OR = 1.31, P = 6.2 × 10 −14 ; Supplementary Table 12 ), and the three previously reported SNPs remained significant after conditioning on rs7763262. Notably, we detect a stronger effect for rs7763262 in Europeans (OR = 1.49, P = 1.2 × 10 −30 ) than in Asians (OR = 1.30, P = 1.2 × 10 −10 ; Supplementary Table 6 ; P value for the OR difference = 0.012). To identify specific HLA alleles that might underlie associations in this region, we imputed classical HLA alleles ( Supplementary Table 13 ). Stepwise conditional analysis identified four independent genome-wide significant associations ( Supplementary Table 14 ), including HLA-DQA1*0101 (OR = 1.53, P = 1.7 × 10 −15 ), HLA-DQA1*0102 (OR = 0.68, P = 1.7 × 10 −14 ), HLA-DQB1*0201 (OR = 0.71, P = 2.6 × 10 −13 ) and HLA-DQB1*0301 (OR = 1.33, P = 2.2 × 10 −12 ). On conditional analysis, these classical alleles accounted for most of the SNP associations at this interval (Supplementary Table 15 ). The previously reported risk allele at 6p21 (rs2071543, encoding a p.Gln49Lys missense variant in PSMB8) 3 represents a strong cis expression quantitative trait locus (eQTL) associated with increased peripheral blood expression of TAP2, PSMB8 and PSMB9 (ref. 8) , which encode proteins involved in antigen processing and presentation ( Supplementary Table 9 ). In this study, rs2071543 displayed significant heterogeneity across different cohorts (I 2 = 76%, Cochrane's P < 0.05) attributable to ancestry-specific effects ( Supplementary  Table 6 ). This SNP was genome-wide significant in Asians (OR = 1.41, P = 2.1 × 10 −9 ), but no association was observed in Europeans (OR = 0.99, P = 0.85). This difference was not explained by differences in risk allele frequency in Asian and European controls (0.80 and 0.87, respectively), suggesting variation in LD structure between Europeans and Asians or the presence of an Asian-specific risk allele at this locus.
A GWAS in Asians previously implicated rs2738048 in the DEFA locus at 8p23, which contains a cluster of related genes encoding the α-defensin antimicrobial peptides 4 . We detected a new genome-wide significant signal in this region represented by rs10086568 (OR = 1.16, P = 1.0 × 10 −9 ; Fig. 1e ). Data for all cohorts, regardless of ancestry, supported this new association. In contrast, we observed only a weak association at rs2738048 (OR = 1.10, P = 1.6 × 10 −4 ), with evidence of significant heterogeneity across different cohorts (Cochrane's P < 0.05). In ancestry-specific analyses, the association of rs2738048 was evident only in Asian cohorts (OR = 1.23, P = 1.3 × 10 −7 in Asians; OR = 1.02, P = 0.58 in Europeans; Supplementary Table 6 ), and this finding was not explained by differences in the risk allele frequency in Asian and European controls (0.68 and 0.69, respectively). Because rs2738048 and rs10086568 were not in LD (r 2 < 0.03), mutual conditioning had little effect on these results ( Supplementary Table 16 ). Thus far, variation at this locus has not been identified by GWAS of other phenotypes, suggesting that the DEFA association might be specific to IgAN.
Replication of four other known loci and total variance explained
Our GWAS provided genome-wide significant confirmation of three previously reported loci at 1q32 (CHFR3-CHFR1 deletion), 6p21 (HLA-DP) and 22q12 (HORMAD2) and confirmed one of the two previously reported SNPs at 17p13 (TNFSF13, rs3803800) ( Fig. 1 , Table 2 and Supplementary Fig. 6 ). We also confirmed the additive effect of the TNFSF13 and HORMAD2 risk alleles on serum IgA levels ( Supplementary Fig. 7) . Cumulatively, the 15 new and replicated GWAS loci explained 6.2% of the risk in the Europeanancestry cohorts and 7.6% of the variation in disease risk in the Chinese cohorts. 
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The genetic risk score is associated with the age of disease onset We hypothesized that a higher burden of susceptibility alleles might influence the severity or onset of kidney disease. To test this hypothesis, we computed a genetic risk score as the weighted sum of the number of risk-associated alleles multiplied by the log of the OR for each of the individual loci. We detected a highly significant association between the genetic risk score and age of diagnosis among the 3,409 cases with available data (Fig. 2b,c) . In total, 14 of 15 risk alleles promoted earlier disease onset ( Supplementary Table 17 ), with each quintile of the genetic risk score changing the age of onset by 1.2 years (P = 2.8 × 10 −13 ). This effect was robust to adjustments for cohort or ancestry. Nonetheless, these loci explained only about 1.4% of the total variance in age of disease onset. Additional analysis of single SNP-phenotype correlations pointed to the rs7763262[C] risk allele (at the HLA-DQ-HLA-DR locus) as being most strongly associated with age of diagnosis (P = 3.2 × 10 −4 ) and greater risk of progression to end-stage kidney disease (per-allele hazard ratio (HR) = 1.72, P = 3.6 × 10 −3 ). Exploratory analyses of other parameters of disease severity and progression were generally not statistically significant ( Supplementary Tables 17-19 ).
Geospatial pattern of genetic risk suggests polygenic adaptation
We previously demonstrated that the worldwide distribution of IgAN risk alleles was correlated with distance from Africa and paralleled the prevalence of IgAN 2,3 . The distribution for the 15-SNP risk score derived from the present study showed an even greater difference among worldwide populations and was more correlated with geography (52 Human Genome Diversity Panel (HGDP) populations, r = 0.33, P < 1.0 × 10 −16 ; Supplementary Fig. 8a ).We observed no evidence of hard selective sweeps at any of the individual loci by haplotype-based selection tests in Asians and Europeans 16 . For several loci, ancestral alleles had lower frequencies in Africans, suggesting that local selective pressures could be operating in Africa. The observed correlation of the risk score with distance from Africa is unlikely to Number of risk alleles 29 28  27  26  25  24  23  22  21  20  19  18  17  16  15  14  13  12  11  10  9  8  7  6 Mean age at diagnosis (years) 
npg
A r t i c l e s be a chance event: performing 10,000 permutations of 15 randomly drawn SNPs matched for average allele frequency to each IgAN SNP, we found that the observed geospatial correlation was in the upper tail of the null distribution (empirical P = 0.026; Supplementary Fig. 8b) .
The IgAN risk allele frequencies were also highly differentiated across HapMap 3 populations (average F ST , which measures variation in allele frequencies among populations, of 0.237; Supplementary  Table 20) . Notably, the risk alleles with larger effect size displayed greater differences in frequency among populations, further suggesting a non-random change in allele frequency across populations ( Supplementary Fig. 8d,e ). Taken together, these observations are best explained by polygenic adaptation to local environments (soft ITGAM and ITGAX encode integrins αM and αX that mark intestinal dendritic cells that maintain the balance between inflammation and tolerance. ITGAM and ITGAX also combine with the integrin β2 chain to form leukocyte-specific complement receptors 3 and 4 (CR3 and CR4, respectively). ITGAM is involved in the regulation of intestinal IgA-producing plasma cells in mice 36 .
Integrin αM-positive IgA plasma cells reside in Peyer's patches, require microbial stimulation for development and exhibit more proliferation and more IgA production than integrin αM-negative cells 36 .
In mice, intestinal dendritic cells that express high level of both the αM and αX integrins are CD103 + , express TLR5, produce retinoic acid and induce T cell-independent IgA class-switch recombination 52, 53 . Schistosome infection specifically impairs the ability of ITGAM-positive (CD11b + ) dendritic cells to stimulate CD4 + T cells 49 .
CARD9
NOD-like receptor signaling pathway, innate immune system, tuberculosis, fungal infection CARD9 encodes a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-κB signaling, which is responsible for both innate and adaptive immune responses 54 . The rs4077515 risk allele is associated with increased expression of CARD9 and has a known association with increased risk of ulcerative colitis and Crohn's disease 11, 12, 34, 55, 56 . Conversely, a rare protein-truncating splice-site variant in CARD9 confers additive protection from IBD 56, 57 . Familial CARD9 deficiency predisposes to invasive fungal infections 58 . CARD9 mediates intestinal repair, T helper 17 responses and control of bacterial infection after intestinal epithelial injury in mice 41 .
VAV3
Chemokine signaling pathway, focal adhesion, natural killer cell-mediated cytotoxicity, T cell receptor signaling pathway, B cell receptor signaling pathway, FcεRI signaling pathway, FcγR-mediated phagocytosis, leukocyte transendothelial migration, regulation of actin cytoskeleton VAV proteins (VAV1, VAV2 and VAV3) are guanine nucleotide exchange factors essential for adaptive immune function 13, 14 and NF-κB activation in B cells, in a process that stimulates IgA production 43 . VAV proteins are also required for the proper differentiation of colonic enterocytes and the prevention of spontaneous ulcerations of intestinal mucosa 42 . VAV3 is a positional candidate QTL for mouse intestinal inflammation in a parasiteinduced (Trichuris muris) model of infection 59 .
DEFA1, DEFA3, DEFA4, DEFA5, DEFA6
Innate immune system α-defensins are antimicrobial peptides involved in mucosal defense. The DEFA5 and DEFA6 genes are expressed by intestinal Paneth cells. Deficiencies in α-defensins 5 and 6 have been associated with Crohn's disease 39, 40 . Whereas α-defensin 5 is broadly antimicrobial, α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets 60 .
TNFSF13
Cytokine-cytokine receptor interaction, intestinal immune network for IgA production TNFSF13 encodes APRIL, a powerful B cell-stimulating cytokine that promotes CD40-independent IgA class switching 35 . The IgAN risk allele is associated with increased IgA levels 4 . TNFSF13 is induced by intestinal bacteria, resulting in IgA class switching. APRIL levels are elevated in some individuals with IgAN 61 . Mutations in the gene for the TNFSF13 receptor (TACI) result in IgA deficiency or combined variable immunodeficiency, with an increased propensity to mucosal infections 62 .
LIF, OSM, HORMAD2, MTMR3
Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway
The IgAN risk allele at this locus is protective against Crohn's disease 11, 12, 33 and is associated with increased serum IgA levels 3 . LIF and OSM are interleukin (IL)-6-related cytokines that use gp130 for signal transduction and have previously been implicated in mucosal immunity 63, 64 . Genetic disruption of gp130 signaling leads to gastrointestinal ulceration and inflammatory joint disease in mice 65 . LIF is secreted by pericrypt fibroblasts 66 and might be critical for the proliferation and renewal of enterocytes 67 .
PSMB8, PSMB9, TAP1, TAP2
Phagosome pathway, antigen processing and presentation, primary immunodeficiency, proteasome, activation of NF-κB in B cells PSMB8 and PSMB9 are interferon-induced subunits of the immunoproteasome that mediate intestinal NF-κB activation in IBD 68 . PSMB8 is upregulated in human intestinal tissue with active IBD lesions 69 . Treatment with bortezomib (a PSMB8 inhibitor) or psmb8 deletion in mice attenuates experimental colitis 70 .
HLA-DQA1, HLA-DQB1, HLA-DRB1
Antigen processing and presentation, adaptive immune system, intestinal immune network for IgA production, allograft rejection, graft versus host disease, asthma, autoimmune thyroid disease, Leishmania infection
The IgAN risk allele is associated with increased risk of celiac disease 71, 72 and increased risk of IgA deficiency 24 . The IgAN risk allele has an opposing (protective) effect on risk for ulcerative colitis 27, 73 .
a Canonical pathways are based on those in the Molecular Signature Database (KEGG, Biocarta and Reactome).
npg selective sweeps acting simultaneously on multiple existing loci) or more complex selective pressures not easily detectable by classical tests of selection 17, 18 .
Overlap with susceptibility loci for other phenotypes
We identified many overlaps with the susceptibility loci for other phenotypes documented in the National Human Genome Research Institute (NHGRI) GWAS catalog, suggesting shared pathogenic pathways ( Fig. 2a and Supplementary Table 11 ). We found both concordant and opposing effects in comparisons with other immunemediated diseases. The HLA-DQ-HLA-DR region had the greatest number of overlapping associations: IgAN risk alleles within this locus conferred increased risk of rheumatoid arthritis 19 , systemic sclerosis 20 , alopecia areata 21 , Graves' disease 22 , follicular lymphoma 23 , type 1 diabetes 19 and IgA deficiency 24 . However, these risk alleles for IgAN also reduced risk for SLE 25 , multiple sclerosis 26 , ulcerative colitis 27 and hepatocellular carcinoma 28 . Because of extensive LD within the HLA region, some of these associations might be reflective of signal intercorrelation rather than true pleiotropic effects. Among non-HLA loci, IgAN risk alleles also conferred increased risk for IBD (CARD9 locus) 11, 12 , elevated serum non-albumin protein and IgA levels (TNFSF13 locus) 29 , age-related macular degeneration (CFHR3-CFHR1 deletion locus) 30 and type 1 diabetes (HORMAD2 locus) 31 .
Opposing effects were detected for SLE (ITGAM-ITGAX and CFHR3-CFHR1 deletion loci) 7, 32 and IBD (HORMAD2 locus) 12, 33 .
Notably, detailed annotations showed that the majority of the IgAN loci encoded proteins implicated in maintenance of the intestinal barrier and regulation of the mucosal immune response to pathogens ( Table 3) . Three IgAN risk loci are associated with Crohn's disease and/or ulcerative colitis (CARD9, HORMAD2 and HLA-DQB1) 11, 12, 34 . ITGAM and TNSF13 participate in the regulation of IgA-producing cells in the intestine 35, 36 , and ITGAM is also required for the interaction between FcαR (CD89) and secretory IgA, the main form of IgA at mucosal sites 37, 38 . α-defensins are expressed by intestinal Paneth cells and protect from food-and water-borne pathogens in the intestine; deficiencies in α-defensin 5 and 6 have been associated with Crohn's disease 39, 40 . Finally, CARD9, VAV3, PSMB8 and PSMB9 are involved in NF-κB activation and are essential for maintenance of the intestinal epithelial barrier and control of the local inflammatory response to infection, and CARD9 deficiency results in susceptibility to invasive fungal infections [41] [42] [43] .
Enrichment of the GWAS loci for SNPs implicated in autoimmune or inflammatory traits
We hypothesized that additional associations with other autoimmune and inflammatory disorders might be present below our replication threshold. Therefore, we performed a gene set analysis of 582 non-HLA SNPs previously associated with any autoimmune or inflammatory trait listed in the NHGRI GWAS catalog. In total, 87 of 582 SNPs (15%) were associated with risk of IgAN at a nominal P value of <0.05 npg A r t i c l e s ( Fig. 3a and Supplementary Table 21 ). This distribution of SNPs was never observed in 10,000 permutations of phenotype on genotype, indicating a highly significant excess of positive associations (empirical P < 0.0001; Supplementary Fig. 9 ). We also detected a consistent excess of direct protein-protein interactions among gene products encoded by the significant and suggestive loci ( Supplementary  Fig. 10 ). Among the most prominent autoimmune signals was the PADI4 locus, previously associated with risk of rheumatoid arthritis 44 (rs12568771: OR = 1.12, P = 1.8 × 10 −6 ; Supplementary Table 5 ). These data make it clear that additional associations with other autoimmune and inflammatory disorders are present below our replication threshold, and these signals should be pursued in follow-up studies.
When the suggestive and significant loci were tested for enrichment in Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, the top over-represented pathways were 'intestinal immune network for IgA production' (overlap coefficient of 25%, P < 1.0 × 10 −16 ; Fig. 3b ) and 'Leishmania infection' , a protozoan infection involving the skin, viscera and mucosa (overlap coefficient of 15%, P = 6.8 × 10 −15 ). Notably, the pathway enrichment scores and all network connectivity parameters were consistently increased with the addition of the top SNPs at varying false discovery rate (FDR) levels, providing additional support for the role of these loci in the pathogenesis of IgAN (Supplementary Fig. 10) .
Association of the IgAN genetic risk score with pathogen diversity
The enrichment for pathways involving intestinal immunity and mucosal pathogens strongly suggested that the distinctive geographical pattern of the IgAN risk alleles might have been shaped by an adaption to local environment. To better define potential environmental factors that could account for such an adaptive process, we performed an association analysis of the IgAN genetic risk score for HGDP populations with 14 ecological variables previously defined for these populations that reflect local climate, pathogen load and dietary factors 45 ( Supplementary Table 22a ). Genetic risk was nominally associated with climatic and dietary factors. However, there was a very strong positive association of the IgAN genetic risk score with local pathogen diversity (measured as the number of different pathogen species in the area, including viruses, bacteria, protozoa and helminthes, r = 0.61, P = 6.0 × 10 −7 ; Fig. 4 ). In the analysis of individual pathogen classes, the strongest association was for helminth diversity (r = 0.68, P = 1.0 × 10 −8 ; Fig. 4b) , which accounted for nearly all the association with pathogen diversity on a stepwise regression analysis. In the final combined model, only helminth diversity and geographical location were independently associated with the IgAN genetic risk score ( Supplementary Table 22b ).
DISCUSSION
In this study, we identify six new signals that contribute to IgAN, including four in new loci (ITGAM-ITGAX, VAV3 and CARD9) and two in known regions (HLA-DQB1 and DEFA), and replicate nine of the previously reported genome-wide significant signals. The loci discovered in this study reside at the intersection of multiple canonical pathways and indicate critical steps in the pathogenesis of IgAN (maintenance of the intestinal mucosal barrier, activation of mucosal IgA production, NF-κB signaling, defense against intracellular pathogens and complement activation). Collectively, these 15 independent risk alleles significantly influence the age of disease onset. Moreover, we demonstrate significant overlap of these loci with the loci for other autoimmune and inflammatory disorders, placing IgAN in this disease spectrum.
The striking association of risk allele frequency with geographical location and local helminth diversity is most consistent with multi-locus adaptation to the environment. Although our analysis cannot exclude unmeasured environmental factors or other pathogens that are associated with helminth diversity, helminth infection itself is a potential source of selective pressure. Helminth infection has been a major source of morbidity and mortality in human history and even today occurs in 25% of the world population 46 , with the highest global burden of soil-transmitted helminthes infections occurring in Asia, substantially contributing to pediatric mortality 46, 47 . Intriguingly, secondary forms of IgAN are known to develop in the setting of schistosomiasis, a common helminth infection 48 . Recent data also indicate that schistosome infection specifically impairs the ability of ITGAM-positive (CD11b + ) dendritic cells to stimulate CD4 + T cells 49 . These findings strongly suggest that the increased incidence of IgAN in some geographical areas might represent an untoward consequence of protective adaptation to mucosal invasion by local pathogens. The enhanced immune response conferred by risk alleles would simultaneously explain the known association of mucosal infections as a trigger for IgAN.
Host-pathogen interactions have similarly exerted a critical influence on the genetic architecture of IBD 12 . Consistent with this finding, IgAN loci are either directly associated with risk of IBD (HLA-DQ-HLA-DR, CARD9 and HORMAD2) or encode proteins involved in maintenance of the intestinal mucosal barrier or regulation of the mucosal immune response (DEFA, TNFSF13, VAV3, ITGAM-ITGAX and PSMB8; Table 3 ). Network and enrichment analyses further point to perturbations of the immune pathway of intestinal IgA production as a central defect in disease pathogenesis ( Fig. 3, Supplementary  Fig. 10 and Supplementary Table 21) . These results clearly link intestinal mucosal inflammatory disorders and IBD with risk of IgAN and might explain why these two diseases co-occur more often than expected by chance 50 . These data are also consistent with the clinical observation that mucosal infections frequently trigger episodes of glomerulonephritis in IgAN and with the key role of IgA in defense at mucosal surfaces 51 .
Finally, these results demonstrate that most IgAN risk loci are shared with other immune-mediated diseases and identify 87 suggestive associations with non-HLA SNPs for autoimmune and inflammatory disorders. These analyses predict that follow-up studies of variants for autoimmune and inflammatory disorders, particularly in individuals with an early onset of disease, will yield additional genome-wide significant associations and further clarify links to environmental risk factors.
URLs. The 15-SNP IgAN genetic risk calculator is available at http:// www.columbiamedicine.org/divisions/gharavi/calc_genetic.php. For a full list of the URLs used in data analysis, please refer to the Supplementary Note.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Genotype data can be accessed at the European Genome-phenome Archive (EGA) under accession EGAS00000000031 and at the database of Genotypes and Phenotypes (dbGaP) under accessions phs000431.v1.p1 and phs000431.v2.p1.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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ONLINE METhODS
Study design and power analysis. The study was designed in two stages. Stage 1 (the discovery phase) involved a genome-wide meta-analysis of 4 discovery cohorts (2,747 cases and 3,952 controls) imputed to a common set of >1 million SNPs. Stage 2 (the replication phase) involved genotyping of the top signals from stage 1 in 10 additional cohorts of European and Asian ancestry (4,911 cases and 9,002 controls). We carried out power calculations for this design under the following assumptions: a disease prevalence of 1%; a logadditive risk model; perfect LD between a marker and a disease-associated allele; a follow-up significance threshold of P < 5 × 10 −5 ; and a joint (stage 1 and 2) significance level of P < 5 × 10 −8 . The power of our study was calculated for a range of disease allele frequencies (0.10-0.50) and effect sizes (genotypic risk ratio of 1.10-1.50). The effect sizes detectable at α = 5 × 10 −8 with a power of 80% were also estimated (Supplementary Table 1) . The calculations were performed using CaTS software 74 . All subjects provided informed consent to participate in genetic studies, and the Institutional Review Board of Columbia University as well as local ethics review committees for each of the individual cohorts approved our study protocol. (stage 1) . The cohorts, genome-wide genotyping, genotype quality control, ancestry analysis and imputation are described in detail in the Supplementary Note and Supplementary Tables 2-4 .
GWAS discovery study
We implemented strict quality control filters for each of the cohorts, eliminating samples with low call rates, duplicates, ancestry outliers, samples with cryptic relatedness and samples with a detected sex mismatch (Supplementary Table 2 ). We applied principal component-based ancestry matching algorithms to reduce any potential bias from population stratification ( Supplementary  Table 3 ). After the implementation of ancestry matching, we dramatically reduced the number of significant principal components for each cohort and demonstrated that cases and controls were evenly distributed along the principal-component axes without significant outliers (Supplementary Fig. 1 ). To improve coverage across different platforms, we performed imputation to a common set of >1 million HapMap 3 SNPs ( Supplementary Table 4 and Supplementary Note). Only SNPs with high imputation quality (r 2 > 0.8) were included in association analyses. After ancestry matching, imputation and quality control, there were 4 cohorts included in stage 1: the Italian discovery cohort of 1,045 cases and 1,340 controls (1,132,157 imputed markers), the Chinese discovery cohort of 1,194 cases and 902 controls (1,027,812 imputed markers), the French discovery cohort of 205 cases and 159 controls (1,032,453 imputed markers) and the US discovery cohort of 303 cases and 1,551 controls (1,118,683 imputed markers). Primary association testing was performed within each cohort individually under a multiplicative (log-additive) model and after accounting for imputation uncertainty using an allelic dosage method. Significant principal components of ancestry were included as covariates in the association analysis of each individual cohort. Ancestry-adjusted effect estimates and standard errors were derived for each SNP, and results were combined across the genome using fixed effects. The meta-analysis results were verified using two independent software packages (PLINK v.1.07 (ref. 75 ) and METAL 76 ). Genome-wide distributions of P values were examined visually using quantile-quantile plots for each individual cohort as well as for the combined analysis. We also estimated the genomic inflation factors for each genome-wide analysis 77 (Supplementary Fig. 3) . The final meta-analysis quantile-quantile plot showed no global departures from the expected distribution of P values, and the overall genomic inflation factor was estimated at 1.047 (Supplementary Fig. 4 ).
Follow-up of suggestive signals (stage 2).
On the basis of the examination of the quantile-quantile plots from stage 1, we selected a P-value threshold of 5 × 10 −5 to define signals for follow-up analyses. This threshold corresponds to the positive FDR of 13% (Q-value software) 78 . The threshold defined 435 top SNPs that were subsequently prioritized for replication. Of the 435 SNPs, 320 (74%) were localized within known susceptibility loci, including 286 SNPs across the HLA loci, 30 SNPs at 22q12.2 (HORMAD2 locus) and an additional 4 SNPs at 1q32 (CFHR3-CFHR1 deletion locus). The remaining 115 SNPs were clustered into distinct loci on the basis of their physical location and regional patterns of LD. Conditional logistic regression analysis was carried out to confirm correct SNP grouping and to detect independent association signals. For follow-up genotyping, we prioritized the independent SNPs with the lowest P value in each independent locus. We additionally required that each SNP be successfully typed or imputed in at least three of the four cohorts analyzed. We excluded loci supported by only a single SNP ('singleton signals' defined by the absence of supporting signals with P < 0.01 within the same LD block). When genotyping failed, we selected a backup SNP on the basis of its strength of association, LD with the top SNP, quality of genotyping or imputation, and success in the design of working primers. Additionally, we included representative SNPs for the two recently discovered GWAS-identified loci in Chinese 4 , the TNFSF13 locus (rs3803800 and rs4227) and the DEFA locus (rs2738048). In total, we successfully acquired and analyzed genotype data for 50 carefully selected SNPs representative of the top 37 distinct genomic regions in 13,913 replication samples (4,911 cases and 9,002 controls). The composition of the replication cohorts, genotyping methods and genotype quality control are summarized in the Supplementary Note and Supplementary Table 2 . Association analyses were first carried out individually within each of the ten cohorts included. As in stage 1, the results were next combined using a fixed-effects model. For each SNP, we derived pooled effect estimates, their standard errors and 95% confidence intervals. We also estimated the degree of heterogeneity using the heterogeneity index (I 2 ) and Cochrane's Q test in the combined analysis 79 . The complete summary of association results for all 50 SNPs tested in replication cohorts is provided in Supplementary Tables 5-7. Imputation analysis of classical HLA alleles. For each of the cohorts with available genome-wide genotype data, we imputed classical HLA alleles at the HLA-A, HLA-B, HLA-C, HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. We used HapMap CEU samples (Utah residents of Northern and Western European ancestry) as the reference for the imputation of European-ancestry cohorts and combined the Han Chinese in Beijing, China (CHB) and Japanese in Tokyo, Japan (JPT) samples for Asians. The reference panels were constructed by phasing combined SNP genotype and HLA typing data. Phasing and imputation were performed using two independent methods: MACH 80 and BEAGLE-3 (ref. 81) . Any poorly imputed alleles (R 2 < 0.3) were eliminated from association testing at the level of the individual cohorts. The imputed allelic concordance rate between the two methods was 98.1%. In addition, direct sequencing of the informative coding segments of the HLA-DQB1 gene in a random subset of 155 samples demonstrated that our imputation had 89.0% sensitivity and 91.5% specificity. The association testing in each cohort was performed using the allelic dosage method with adjustment for significant principal components in PLINK 75 . The final results were combined across cohorts using fixed-effects meta-analysis in METAL 76 ( Supplementary  Table 13 ). Conditional analyses were performed using stepwise logistic regression with the Bayesian information criterion (BIC) as a selection criterion ( Supplementary Table 14 ;
Step function in R version 3.0).
Pairwise epistasis screen.
We screened all possible pairwise interaction terms for association with disease using 1-degree-of-freedom likelihood ratio testing (LRT) comparing two nested logistic models: one with main effects only and one with main effects and a multiplicative (log-additive) interaction term. We included cohort membership as a fixed covariate in both models. We excluded 7 pairwise interaction terms between SNPs in partial LD (r 2 > 0.1), resulting in a total of 98 independent interactions tested ( Supplementary Table 23 ). Results were ranked in order of significance, and q values were calculated. Suggestive interaction terms were defined as exceeding a significance threshold that was Bonferroni corrected for the number of independent tests (P < 0.05/98, or 5 × 10 −4 ).
Interrogation of protein-protein interaction networks. We interrogated two comprehensive protein-protein interaction network data sets using two independent methods. First, we used the Disease Association Protein-Protein Link Evaluator (DAPPLE) 82 . This is a network connectivity tool based on InWeb 83 , an integrated database of known interactions with 12,793 nodes and 169,810 high-confidence interactions based on MINT, IntAct, BIND, PPrel, ECrel and Reactome data. The statistical significance of the network connectivity parameters for individual proteins and for the entire seed set was assessed using 1,000 within-degree node label permutations (Supplementary Fig. 10) . In an npg independent confirmatory analysis, we downloaded the Protein Interaction Network Analysis (PINA) data set 84 , which combines annotated protein-protein interaction data from six databases (MINT, IntAct, DIP, BioGRID, HPRD and MIPS/MPact). This large network consisted of 14,784 nodes and 107,802 unique edges (last released on 10 December 2012). To integrate our GWAS results with protein-protein interaction data and to identify modules enriched for disease-associated genes, we used a dense module searching method (dmG-WAS v.2.0) 85 . Briefly, we performed a global search for modules with a maximum proportion of low P values by designating the top-scoring GWAS genes as seeds and selecting neighboring nodes (with the shortest path to any node in the module of ≤2) that optimized the overall significance of the subgraph. The extracted subnetworks were merged and visualized using R (igraph v.0.5.2).
Other methods of prioritizing candidate genes. To interrogate putative functional SNPs that were not typed or imputed in our data set, we systematically identified all variants that were in high LD (r 2 > 0.5) with the 15 IgAN GWAS SNPs on the basis of 1000 Genomes Project data. These variants were further annotated using ANNOVAR 86 , SeattleSeq 87 and HaploReg2 (ref. 88) ( Supplementary Table 10 ). We also analyzed a subset of 1,073 SNPs that represented markers for known common copy number polymorphisms 89 . Additionally, we identified all genes whose expression was correlated with IgAN susceptibility SNPs in cis or trans at P < 1 × 10 −5 ( Supplementary Table 9 ). For this purpose, we used the following recently published eQTL data sets: (i) a meta-analysis of the transcriptional profiles from the peripheral blood cells of 5,311 Europeans 8 , (ii) the transcriptional profiles of primary immune cells (B cells and monocytes) from 288 healthy Europeans 9 , (iii) the transcriptional profiles of 400 lymphoblastoid cell lines derived from asthmatic children 10 and (iv) the eqtl.uchicago browser with compile data across several tissues. Finally, we used GRAIL (Gene Relationships Across Implicated Loci), an online tool that uses PubMed text mining results to assess the network connectivity for genes residing in GWAS-implicated loci 90 . To prioritize candidate genes, each individual gene was tested for significant enrichment in GRAIL connectivity to genes residing in other loci.
Genetic risk score. To assess the cumulative effects of the newly detected loci, we built a logistic regression model based on the 15 SNP predictors with independent contribution to disease risk. The risk score was calculated as a weighted sum of the number of risk alleles at each locus multiplied by the log of the adjusted OR for each of the individual loci. The percentage of the total variance explained was estimated by Nagelkerke's pseudo R 2 from the logistic regression model with the risk score as a quantitative predictor and disease state as an outcome (SPSS Statistics v.21.0, IBM).
Geospatial risk analysis.
For this purpose, we used publicly available genotype data from HapMap 3 (1,184 individuals representative of 11 populations) and HGDP (1,050 individuals representative of 52 worldwide populations). The HGDP individuals had previously been genotyped for 660,918 markers using Illumina HumanHap 650Y arrays (Stanford University). High-quality genotype data were available for 13 of the 15 IgAN SNPs, with missing genotypes for rs10086568 and rs7763262. We imputed rs7763262 with high confidence (imputation r 2 > 0.99) using all HapMap 3 populations in combination as the reference. Instead of rs10086568, we used a near-perfect proxy, rs9644778 (r 2 = 94%, D′ = 1.00), which was also genome-wide significant in our study (P = 1.8 × 10 −9 ). Using these data, we calculated individual risk score profiles for all individuals in the HGDP data set. The risk score was standardized across populations using a z-score method, where standardized risk score = (individual risk score -worldwide mean)/worldwide standard deviation. The median standardized risk scores for each population were compared across continents. We correlated standardized risk profiles with the longitude, latitude and geographical distance from Africa.
Testing for genetic drift. To evaluate whether the observed allelic differentiation was due to genetic drift, we analyzed 10,000 sets of SNPs randomly drawn from the genome but matched to the IgAN SNPs by average minor allelic frequency on a per-SNP basis. In each permutation round, we scored all 1,050 HGDP individuals with the risk score calculated from the set of randomly selected SNPs. The risk scores were correlated with the distance from with IgAN. The directionality of the allelic effects was assessed to identify pleiotropic alleles with concordant or opposed effects ( Supplementary  Table 11 ). We calculated a maximum r 2 value between SNPs associated with each catalogued trait and the 15 SNPs from our study based on data from HapMap 3 and the 1000 Genomes Project. We defined susceptibility alleles as being overlapping if r 2 exceeded 0.50. Lastly, we constructed a susceptibility overlap map that connected each of the IgAN loci to those previously associated with GWAS traits and highlighted associations with SNPs in high LD with the top IgAN signals (Fig. 2a) .
Testing the inflammatory and autoimmune subset hypothesis. We analyzed 582 unique SNPs representative of the 11,276 non-HLA GWAS loci associated with autoimmune and inflammatory diseases listed in the NHGRI GWAS catalog (September 2013) 95 . The association results for this set were visually examined for the over-representation of significant signals using a quantilequantile plot (Fig. 3a) . Next, we tested the autoimmune hypothesis using a previously published hypothesis-driven GWAS (GWAS-HD) approach 96 . This approach involved testing 582 unique SNPs simultaneously for association with IgAN using the GWAS discovery cohorts. To preserve the LD pattern between SNPs, the IgAN phenotype was permuted 10,000 times within each cohort. In each round of permutation, corresponding association analysis was performed using logistic regression after adjustment for cohort membership, and a sum of the Wald (1-degree-of-freedom) association statistics for the 582 SNPs was calculated. The empirical P value was calculated as the proportion of the permutation samples whose sum statistic was larger than that in the observed sample (Supplementary Fig. 9 ).
Gene annotation and network analysis of autoimmune and inflammatory
SNPs. On the basis of the observed distribution of P values, we defined two arbitrary thresholds for the inclusion of suggestive signals in downstream network analyses: a positive FDR of <10% (corresponding to P < 5.9 × 10 −3 ) and a positive FDR of <25% (corresponding to P < 0.05). The SNPs meeting these criteria were clustered into distinct loci on the basis of genomic location and pairwise LD. The disease locus was defined by the nearest recombination hotspots upstream and downstream of the top SNP, and overlapping intervals were merged into a single locus. All genes that intersected this interval, including 100 kb upstream and 40 kb downstream of the largest isoform (to include regulatory DNA), were considered to be contained within the disease locus. Candidate gene sets (constituting the union of all genes within the candidate loci) were used as seeds in sequential GRAIL and DAPPLE analyses (Supplementary Fig. 10 ). These gene sets were also used for pathway analysis in gene set enrichment analysis (GSEA) 97 . The KEGG pathway enrichment map (Fig. 3b) was constructed using Enrichment Map (v.1.2) 98 . Network graphs were visualized in Cytoscape (v.2.8).
